After-hours movers: GameStop, Dave & Buster's, Viridian Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Viridian Therapeutic (VRDN) PT Raised to $31 at Goldman Sachs
September 12, 2024 5:07 AM EDTGoldman Sachs analyst Richard Law raised the price target on Viridian Therapeutic (NASDAQ: VRDN) to $31.00 (from $25.00) while maintaining a Buy rating.
The analyst comments "We update our model to reflect increased POS for veligrotug (VRDN-001) following positive topline results from the Ph. 3 THRIVE... More
William Blair Reiterates Outperform Rating on Dave & Buster's (PLAY)
September 11, 2024 6:58 AM EDTWilliam Blair analyst Sharon Zackfia reiterated an Outperform rating and {REMOVEPT} price target on Dave & Buster's (NASDAQ: PLAY)
The analyst comments "Given challenging near-term trends, we continue to expect negative comps to persist through the remainder of fiscal 2024, yielding an approximate 5% same-store... More
Truist Securities Reiterates Buy Rating on Dave & Buster's (PLAY)
September 11, 2024 5:15 AM EDTTruist Securities analyst Jake Bartlett reiterated a Buy rating and $59.00 price target on Dave & Buster's (NASDAQ: PLAY).
The analyst comments "We expect sales initiatives will start to offset macro headwinds, especially in 4Q24: We attribute slowing SSS in 2Q24 (now slightly below '19 levels on a compounded basis) to macro pressures, which have overwhelmed PLAY's sales drivers to date,... More
BMO Capital Reiterates Outperform Rating on Dave & Buster's (PLAY)
September 11, 2024 5:13 AM EDTBMO Capital analyst Andrew Strelzik reiterated an Outperform rating and $55.00 price target on Dave & Buster's (NASDAQ: PLAY).
The analyst comments "FY2Q24 EBITDA of $152 million exceeded consensus by $11 million as stronger restaurant margins and lower G&A more than offset softer comps.... More
